IBDEI0LP ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10290,1,3,0)
 ;;=3^Conjunctival Sac,Foreign Body
 ;;^UTILITY(U,$J,358.3,10290,1,4,0)
 ;;=4^930.1
 ;;^UTILITY(U,$J,358.3,10290,2)
 ;;=^275486
 ;;^UTILITY(U,$J,358.3,10291,0)
 ;;=930.8^^44^562^33
 ;;^UTILITY(U,$J,358.3,10291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10291,1,3,0)
 ;;=3^Eye,Oth/Combined Sites,Foreign Body
 ;;^UTILITY(U,$J,358.3,10291,1,4,0)
 ;;=4^930.8
 ;;^UTILITY(U,$J,358.3,10291,2)
 ;;=^275488
 ;;^UTILITY(U,$J,358.3,10292,0)
 ;;=940.0^^44^562^8
 ;;^UTILITY(U,$J,358.3,10292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10292,1,3,0)
 ;;=3^Chemical Burn,Periocular
 ;;^UTILITY(U,$J,358.3,10292,1,4,0)
 ;;=4^940.0
 ;;^UTILITY(U,$J,358.3,10292,2)
 ;;=^275512
 ;;^UTILITY(U,$J,358.3,10293,0)
 ;;=940.1^^44^562^35
 ;;^UTILITY(U,$J,358.3,10293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10293,1,3,0)
 ;;=3^Eyelid,Burns
 ;;^UTILITY(U,$J,358.3,10293,1,4,0)
 ;;=4^940.1
 ;;^UTILITY(U,$J,358.3,10293,2)
 ;;=^275513
 ;;^UTILITY(U,$J,358.3,10294,0)
 ;;=940.2^^44^562^18
 ;;^UTILITY(U,$J,358.3,10294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10294,1,3,0)
 ;;=3^Cornea/Conj,Alkaline Burn
 ;;^UTILITY(U,$J,358.3,10294,1,4,0)
 ;;=4^940.2
 ;;^UTILITY(U,$J,358.3,10294,2)
 ;;=^275514
 ;;^UTILITY(U,$J,358.3,10295,0)
 ;;=940.3^^44^562^17
 ;;^UTILITY(U,$J,358.3,10295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10295,1,3,0)
 ;;=3^Cornea/Conj,Acid Burn
 ;;^UTILITY(U,$J,358.3,10295,1,4,0)
 ;;=4^940.3
 ;;^UTILITY(U,$J,358.3,10295,2)
 ;;=^275515
 ;;^UTILITY(U,$J,358.3,10296,0)
 ;;=940.4^^44^562^19
 ;;^UTILITY(U,$J,358.3,10296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10296,1,3,0)
 ;;=3^Cornea/Conj,Oth Burn
 ;;^UTILITY(U,$J,358.3,10296,1,4,0)
 ;;=4^940.4
 ;;^UTILITY(U,$J,358.3,10296,2)
 ;;=^275516
 ;;^UTILITY(U,$J,358.3,10297,0)
 ;;=941.12^^44^562^31
 ;;^UTILITY(U,$J,358.3,10297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10297,1,3,0)
 ;;=3^Eye Erythema
 ;;^UTILITY(U,$J,358.3,10297,1,4,0)
 ;;=4^941.12
 ;;^UTILITY(U,$J,358.3,10297,2)
 ;;=^275531
 ;;^UTILITY(U,$J,358.3,10298,0)
 ;;=977.8^^44^562^4
 ;;^UTILITY(U,$J,358.3,10298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10298,1,3,0)
 ;;=3^Allergy to Fluorescein
 ;;^UTILITY(U,$J,358.3,10298,1,4,0)
 ;;=4^977.8
 ;;^UTILITY(U,$J,358.3,10298,2)
 ;;=^276154
 ;;^UTILITY(U,$J,358.3,10299,0)
 ;;=989.83^^44^562^111
 ;;^UTILITY(U,$J,358.3,10299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10299,1,3,0)
 ;;=3^Toxic Effect of Silicone
 ;;^UTILITY(U,$J,358.3,10299,1,4,0)
 ;;=4^989.83
 ;;^UTILITY(U,$J,358.3,10299,2)
 ;;=^303356
 ;;^UTILITY(U,$J,358.3,10300,0)
 ;;=995.29^^44^562^3
 ;;^UTILITY(U,$J,358.3,10300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10300,1,3,0)
 ;;=3^Adverse Effect of Drug
 ;;^UTILITY(U,$J,358.3,10300,1,4,0)
 ;;=4^995.29
 ;;^UTILITY(U,$J,358.3,10300,2)
 ;;=^334181
 ;;^UTILITY(U,$J,358.3,10301,0)
 ;;=998.30^^44^562^25
 ;;^UTILITY(U,$J,358.3,10301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10301,1,3,0)
 ;;=3^Disruption OP Wound
 ;;^UTILITY(U,$J,358.3,10301,1,4,0)
 ;;=4^998.30
 ;;^UTILITY(U,$J,358.3,10301,2)
 ;;=^336767
 ;;^UTILITY(U,$J,358.3,10302,0)
 ;;=998.31^^44^562^27
 ;;^UTILITY(U,$J,358.3,10302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10302,1,3,0)
 ;;=3^Disruption of Internal OP Wound
 ;;^UTILITY(U,$J,358.3,10302,1,4,0)
 ;;=4^998.31
 ;;^UTILITY(U,$J,358.3,10302,2)
 ;;=^336843
 ;;^UTILITY(U,$J,358.3,10303,0)
 ;;=998.32^^44^562^26
 ;;^UTILITY(U,$J,358.3,10303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10303,1,3,0)
 ;;=3^Disruption of External OP Wound
 ;;^UTILITY(U,$J,358.3,10303,1,4,0)
 ;;=4^998.32
 ;;^UTILITY(U,$J,358.3,10303,2)
 ;;=^336844
 ;;
 ;;$END ROU IBDEI0LP
